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treatment policies have changed considerably
over the last years, in this retrospective study
we analysed teasibility ot radical radiotherapy
and outcomes ot patients treated in our
institution between 1992 and 2000. Study group
comprised 49 consecutive BC patients aged 43
to 80 years (median 71), including three cases
with clinically involved pelvic Iymph nodes.
There were 45 urothelial, and tour other types ot
cancer (grade 1- tour, 2 - 21, 3-nine, and
unknown -14 cases). Six patients were reterred
tor radiotherapy atter nonradical operation.
Treatment was delivered with the use ot 60Co or
LA tive days a week, without planned
interruptions. Thirty-two patients received
elective irradiation ot the pelvic Iymph nodes to
the dose 40 to 48Gy, toJlowed by the boost to
the bladder to the total dose 60 to 66Gy.
Seventeen patients received total dose ot 58 to
62Gy to the bladder and perivesical tissue.
Fraction doses ranged trom 1.8 to 2.0Gy.
Treatment was prematurely stopped due to
disease progression (PD), patient retusal,
uraemia, in one case each, and intractable
diarrhoea in six cases. After a median tollow-up
ot 14 months (range 1 - 102) 23 patients died ot
PD. Median survival in the entire group is 159
months. Results ot this study contirm relative
etficacy of radiotherapy in BC. Further
refinement ot radiotherapy techniques is
warranted to improve the outcome.
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Od października 1999 roku oprócz radioterapii
zastosowaliśmy leczenie pamidronianem
sodowym u 32 chorych z osteolitycznymi
przerzutami raka do kości. Przyjęliśmy dawkę
90mg we wlewie dożylnym co 4 tygodnie,
łącznie podano 166 kroplówek. Wiek chorych
wahał się od 33 do 81 lat (mediana 62 lata).
U 12 pacjentów rozpoznano raka gruczołu
krokowego, u 6 - nerki, u 6 - sutka u kolejnych
6 - płuca, u 1 - ślinianki, a u dwóch nie
znaleziono punktu wyjścia nowotworu (u jednego
pacjenta rozpoznano dwa nowotwory - płuca
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i gruczołu krokowego). Dwunastu pacjentom
podano jeden lub dwa wlewy dożylne
pamidronianu i w tej grupie aktualnie nie
możemy oceniać wyników leczenia. Dwudziestu
chorym podano większą ilość kroplówek
(3 - 17). W tej grupie 13 nadal pozostaje
w trakcie leczenia, z wycofaniem się bądź
znacznym zmniejszeniem dolegliwości bólowych
ocenianych według VAS (początkowo 4-8,
aktualnie 0-3). Natomiast u. 7 przerwano
leczenie ze względu na progresję choroby
i pogorszenie stanu ogólnego. U kilku chorych
wykonane kontrolne zdjęcie radiologiczne kości
wykazały częściowe uwapnienie przerzutu.
Obserwowaliśmy niewiele i słabo nasilonych
objawów ubocznych leku (6 chorych - objawy
grypopodobne, 2 - nudności).
Powyższa analiza zachęca do kontynuowania
stosowania pamidronianu dwusodowego
u chorych z przerzutami do kości w przebiegu
raka o różnej lokalizacji.
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VARIANTS OF PREOPERATIVE
THERMORAOIOTHERAPY IN
LOCALLY AOVANCEO BREAST
CANCER PATIENTS
O. Trofimova, 5.1. Tkachev, V.M. Ivanov
Cancer Research Centre, Moscow
To improve treatment results ot locally
advanced breast cancer 60 patients with T3-
4N1-2MO TNM stage were undergone complex
treatment at the Dept. ot Radiotherapy ot the
CRC. The treatment complex included: radio- or
thermoradiotherapy and polychemiohormone-
therapy. Ali patients were subdivided into 3
groups. The tirst group ot 20 patients received
radiotherapy only, the second one (18 patients)
- thermoradiotherapy, and the third group ot 22
patients - thermoradoitherapy plus additional
local irradiation ot the primary and/or big
Iymphnode metastases. Radiotherapy was with
2 Gy tractions 5 times per week to the primary
tumor and Iymphcollectors. Total dose was 40-
50 Gy. Results ot the therapy were evaluated
after 3-4 weeks and the patients were received
a surgery' The second group ot the patients
received local hypertherima after 2 weeks ot
conventional treatment. Primary tumor and big
metastatic nodes were heated. Hyperthermia
was peńormed 2 times per week, with duration
ot 60 minutes, 3 hours atter irradiation.
Temperature in tumor was 43-45C. In the third
group ot patients additional boost to tumor
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and/or big metastatic nodes was performed with
2 Gy fractions. Total doses were the same as in
first and second group, local tumor dose was
64-72 Gy. Complete or partial regression was
more frequently registered in tirst and second
group (39%, 62% respectively). In tirst group
rate was 2%. Rate ot postirradiation
pathomorphosis ot 3-4 grade was 35% in tirst
group, 50% in second, 66% in third group. This
data shows improvement ot nearest treatment
results.
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Introduction: We analyzed correlation
between age ot patient with anaplastic
meningiomas, extension ot tumor excision,
histopatological recognition and time to
recurrence and survival.
Material and methods: Between 1990-1997
7 patients with anaplastic meningioma, 3
patients with haemangiopericytoma, 2 patients
with sarcoma meningeum (6 women and 6 men)
have been irradiated. 7 patients underwent
radical excision ot the tumor, 5 patients non
radical. The patients were irradiated trom Iimited
tields to total dose 56-60 Gy/T mostly by energy
Co-60 (9 patients) and photons 9MV (3
patients).
Results: There are 6 patients with
anaplasticum meningioma stilI alive. 3 patients
living 96·108 months, 3 other 30-39 months.
Recurrence was contirmed in two male
participants who underwent radical surgery in 12
and 29 month trom the start ot treatment. The
tirst patient died after 16 months with recurrence
ot the disease. One patient (39 years old) with
heamangiopericytoma Iives 40 months after
radical surgery without evidence ot recurrence.
Two patients died - one 11 months after radical
surgery (41 years old) and the other one (42
years old) 21 months after non radical surgery.
Both patients (24 and 59 years old) with
sarcoma died (one after 8 months, and the other
one after 21 months).
Conclusions: Patient with anaplastic
meningiomas have long survival. The extension
ot tumor excision didn't influence on survival.
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Introduction: Low-grade glicomas represents
15% of aU primary brain tumors.
Material and Method: Between 1990-97 63
patient with low-grade gliomas were treated in
Greatpoland Cancer Center (39 males, 24
females; age between 20-60 year). 15 patients
had andegrone complete surgical excision, 48
partialor subtotal excision ot tumor. The trontal
lobe was affected in 33 patients, the temporai
lobe in 14 patients. Patients received
conventional irradiaton ot 60Gy.
Results: *Five patients with histologically
verified pilocytic astrocytomas(l) were treated
after partial excision, median of age 29.2year
median survival 58 months(27-108) Only one
patient died 27months after radiotherapy.
*Thirteen patients with fibrylar astrocytomas(II)-
11 post subtotal excision-median age 37.7year
median survival 32.5months. Recurrent tumor in
two patients. Five patients are alive. *Ten
patients with protoplasmatic astrocytoma(II)-7
post subtotal excision median ot age 43.5year
median survivaI30.8months. Four patients alive.
*Seven patients with gemistocytic
astrocytomas(ll) (6 post subtotal excision)-
median age 36year, median survival 32months.
Only one patient alive. *Eleven patients with
0Iigoastrocytomas(II)-11 post subtotal excision,
median age 38.6 year, median survival
43.9months. Two patients with recrrent tumor.
Alive 8 patients. *Seventeen patients with
oligodendrogliomas (11 post subtotal excision)
median age 39 years, median survival
39months. One patien with recrrent tumor. Alive
8 patients.
Conclusions: *30 patients are alive(48%);
*histopathologic diagnosis pilocytic
astrocytomas asociated with age 10 years
younger then either low-grade gliomas and long-
term survivors; *poor prognistic tactor in
gemistocytic astrocytomas-only one patient
alive;*five patients with recurrent tumor among
17 to 49 months after radiotheraphy.
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